Description
Submitted by Guilherme Lemeszenski (guilherme@nead.unesp.br) on 2013-08-22T18:40:20Z No. of bitstreams: 1 S0066-782X2003001400003.pdf: 148829 bytes, checksum: f56caac583fa2d4bd2694c99d9f79c19 (MD5)
Made available in DSpace on 2013-08-22T18:40:20Z (GMT). No. of bitstreams: 1 S0066-782X2003001400003.pdf: 148829 bytes, checksum: f56caac583fa2d4bd2694c99d9f79c19 (MD5) Previous issue date: 2003-12-01
Made available in DSpace on 2013-09-30T19:25:45Z (GMT). No. of bitstreams: 2 S0066-782X2003001400003.pdf: 148829 bytes, checksum: f56caac583fa2d4bd2694c99d9f79c19 (MD5) S0066-782X2003001400003.pdf.txt: 37311 bytes, checksum: 51173195e33aa386ea96511addf82a56 (MD5) Previous issue date: 2003-12-01
Submitted by Vitor Silverio Rodrigues (vitorsrodrigues@reitoria.unesp.br) on 2014-05-20T13:33:02Z No. of bitstreams: 2 S0066-782X2003001400003.pdf: 148829 bytes, checksum: f56caac583fa2d4bd2694c99d9f79c19 (MD5) S0066-782X2003001400003.pdf.txt: 37311 bytes, checksum: 51173195e33aa386ea96511addf82a56 (MD5)
Made available in DSpace on 2014-05-20T13:33:02Z (GMT). No. of bitstreams: 2 S0066-782X2003001400003.pdf: 148829 bytes, checksum: f56caac583fa2d4bd2694c99d9f79c19 (MD5) S0066-782X2003001400003.pdf.txt: 37311 bytes, checksum: 51173195e33aa386ea96511addf82a56 (MD5) Previous issue date: 2003-12-01
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
OBJETIVO: Caracterizar, evolutivamente, o modelo experimental de hipertrofia ventricular esquerda (HVE) por indução de estenose aórtica supravalvar em ratos jovens. MÉTODOS: Ratos Wistar foram submetidos a toracotomia para colocação de clipe ao redor da aorta torácica (grupo EAo, n=12). Animais controle foram submetidos à mesma cirurgia, porém sem a colocação do clipe (grupo C, n=12). A função cardíaca foi analisada por ecocardiogramas seriados após 6, 12 e 21 semanas. Outros grupos foram utilizados para avaliação histológica e quantificação da hidroxiprolina miocárdica (HOP: 2, 6, 12 e 21 semanas). RESULTADOS: A EAo promoveu precocemente HVE concêntrica e aumento progressivo da concentração de HOP. À microscopia óptica, observou-se hipertrofia dos miócitos e da camada média dos ramos intramurais das artérias coronárias. A função sistólica foi supranormal no período 6 semanas (porcentagem de encurtamento - EAo6:70,3±10,8; C6: 61,3±5,4; p<0,05), apresentando-se reduzida apenas no último período. A partir de 12 semanas, verificou-se disfunção diastólica (E/A - EAo12: 4,20± 3,25; C12: 1,61±0,16; p<0,05). CONCLUSÃO: A indução de EAo promove HVE concêntrica e fibrose miocárdica. A função cardíaca, dependendo do período de análise, encontra-se melhorada, normal ou deprimida. O modelo é adequado e potencialmente útil para estudos sobre a fisiopatologia e tratamento nas diferentes fases evolutivas da hipertrofia cardíaca.
OBJECTIVE: To characterize the follow-up of an experimental model of left ventricular hypertrophy (LVH) induced by supravalvular ascending aortic stenosis in young rats. METHODS: Wistar rats were submitted to thoracotomy and aortic stenosis was created by placing a clip on the ascending aorta (AoS group, n=12). Age-matched control animals underwent a sham operation (C group, n=12). Cardiac function was analysed by echocardiograms performed 6, 12, and 21 weeks after aortic banding. Myocardial morphological features and myocardial hydroxyproline concentration (HOP) were evaluated 2, 6, 12, and 21 weeks after surgery in additional animals. RESULTS: Aortic banding promoted early concentric LVH and a progressive increase in HOP. Under light microscopy, we observed myocyte hypertrophy and wall thickening of the intramural branches of the coronary arteries due to medial hypertrophy. Cardiac function was supranormal after 6 weeks (percentage of fractional shortening - EAo6: 70.3±10.8; C6: 61.3±5.4; p<0.05), and depressed in the last period. Diastolic dysfunction was detected after 12 weeks (ratio of early-to-late filling velocity - EAo12: 4.20±3.25; C12: 1.61±0.16; p<0.05). CONCLUSION: Ascending aortic stenosis promotes concentric LVH with myocardial fibrosis and minimal histological changes. According to the period of evaluation, cardiac function may be improved, normal, or depressed. The model is suitable and useful for studies on pathophysiology and treatment of the different phases of cardiac hypertrophy.
UNESP Faculdade de Medicina de Botucatu
UNESP Faculdade de Medicina de Botucatu
